PSundberg
TL2 Member · Jönköping, SE
Practical questions, practical answers. Not interested in speculation without a source.
Joined 31 July 2025 · last posted 6d
81 posts, newest first. Showing up to 150.
-
Insomnia at a dose step: reported experiences — the long version Replied, post #50 · Wellbeing › Sleep · 22 Jul 2026 · 0 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
-
What a regulator's shortage notice actually authorises Replied, post #10 · Sourcing › Regulatory · 20 Jul 2026 · 1 like Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Which categories are strict and which are relaxed, honestly Replied, post #31 · Start Here › Welcome · 20 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Request: tag synonyms surfaced in search Replied, post #18 · Meta › Feature requests · 14 Jul 2026 · 0 likes Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your feature has already been suggested before posting.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #25 · Analytics › HPLC & UHPLC · 10 Jul 2026 · 0 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
When a dose reduction is the correct response to a side effect Replied, post #37 · Practice › Dosing & titration · 9 Jul 2026 · 2 likes Coming back to post #35, because the follow-up matters more than the original answer. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #37 · Compounds › Secretagogues & GH axis · 5 Jul 2026 · 17 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #10 · Evidence › Journal club · 30 Jun 2026 · 0 likes I read post #8 twice before replying, because I had assumed the opposite. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #82 · Analytics › HPLC & UHPLC · 28 Jun 2026 · 11 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #29 · Research Methods › Statistics · 24 Jun 2026 · 0 likes post #28 answers the question as asked. The question underneath it is different. Number needed to treat: how many people need to be treated to prevent one bad outcome…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #61 · Analytics › HPLC & UHPLC · 22 Jun 2026 · 0 likes On post #57 — agreed on the reasoning, with one qualification. Before anything else: what was the gradient, and at what wavelength? Area percent at different…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #117 · Practice › Reconstitution · 19 Jun 2026 · 2 likes post #116 is right about the mechanism and I think understates the practical bit. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects…
-
Pancreatitis history and the risk calculus Replied, post #20 · Safety › Contraindications · 18 Jun 2026 · 0 likes Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the…
-
Official shortage notices and what they authorise Replied, post #105 · Access › Shortages · 14 Jun 2026 · 4 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
Injection volume, overload, and peak distortion Replied, post #46 · Analytics › HPLC & UHPLC · 11 Jun 2026 · 19 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
The anatomy of a question that gets answered within an hour Replied, post #74 · Start Here › How to Ask · 11 Jun 2026 · 26 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #17 · Compounds › Tirzepatide · 5 Jun 2026 · 7 likes Picking up post #14: that is the part I would want checked first. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #39 · Clinical › Bloodwork · 1 Jun 2026 · 0 likes I read post #37 twice before replying, because I had assumed the opposite. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #70 · Evidence › Journal club · 29 May 2026 · 26 likes post #69 answers the question as asked. The question underneath it is different. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #28 · Practice › Administration · 16 May 2026 · 7 likes On post #24 — agreed on the reasoning, with one qualification. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #114 · Practice › Interactions · 6 May 2026 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #18 · Compounds › Tirzepatide · 3 May 2026 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #23 · Evidence › Study critique · 27 Apr 2026 · 7 likes On post #19 — agreed on the reasoning, with one qualification. Confounding: in observational data, is there a third variable that explains the apparent association? In…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #5 · marked as the solution · Compounds › Tirzepatide · 27 Apr 2026 · 11 likes Worth separating two things that the opening post runs together. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were…
-
Transporting a vial for a weekend away — a second dataset Replied, post #33 · Practice › Storage & stability · 21 Apr 2026 · 32 likes post #32 is right about the mechanism and I think understates the practical bit. Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals…
-
PCOS and metabolic overlap: what is and is not studied Replied, post #2 · Clinical › Comorbidities · 19 Apr 2026 · 0 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Preprint servers and what screening they do Replied, post #96 · Evidence › Preprints · 20 Mar 2026 · 0 likes I read post #94 twice before replying, because I had assumed the opposite. How to cite a preprint: author last name, first initial, et al. Title. Server name…
-
Follow-up: Levothyroxine timing: a real interaction with a simple fix Replied, post #2 · Practice › Interactions · 17 Mar 2026 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Which fields on a certificate actually matter, ranked Replied, post #18 · Analytics › COA interpretation · 16 Mar 2026 · 8 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #32 · Research Methods › N-of-1 designs · 4 Mar 2026 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #11 · Practice › Administration · 3 Mar 2026 · 17 likes I read post #9 twice before replying, because I had assumed the opposite. A genuinely late dose: the labelling generally says that if the next dose is more than a…
-
Open-label extensions: what survives and what does not Started this topic · Evidence › Trials · 24 Feb 2026 · 53 likes Posting this under the heading it deserves: Open-label extensions: what survives and what does not Everything below is what sits behind that. Comparing STEP 8 ( JAMA ,…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #8 · Practice › Administration · 22 Feb 2026 · 11 likes Coming back to post #6, because the follow-up matters more than the original answer. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #55 · Practice › Interactions · 20 Feb 2026 · 2 likes I read post #53 twice before replying, because I had assumed the opposite. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #48 · Outcomes › Progress reports · 13 Feb 2026 · 1 like Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
A history of disordered eating: proceeding carefully Replied, post #69 · Wellbeing › Mental health · 21 Jan 2026 · 11 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #5 · Evidence › Trials · 9 Jan 2026 · 0 likes I read post #3 twice before replying, because I had assumed the opposite. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #57 · Access › Pricing · 9 Jan 2026 · 17 likes Picking up post #54: that is the part I would want checked first. Compute cost per delivered dose at your dose if you want a number you can act on. That requires…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #5 · Regional › UK & Ireland · 7 Jan 2026 · 0 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #82 · Practice › Side effects · 29 Dec 2025 · 0 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
How to ask about something you suspect is a bad idea Replied, post #35 · Start Here › How to Ask · 17 Dec 2025 · 29 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #33 · Data & Tools › Calculators · 9 Dec 2025 · 28 likes post #32 is right about the mechanism and I think understates the practical bit. Offline use: all calculators are written in JavaScript and can be downloaded and run…
-
Request: a diff view for wiki revisions — the long version Replied, post #80 · Meta › Feature requests · 6 Dec 2025 · 14 likes post #79 is right about the mechanism and I think understates the practical bit. Duplicate requests: if several people request the same feature, the requests often get…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #2 · Sourcing › Red flags · 28 Nov 2025 · 0 likes Picking up the opening post: that is the part I would want checked first. Inability to trace lots: if you ask "where was this synthesised, by whom, under what…
-
Meeting a protein target on a suppressed appetite Replied, post #35 · Nutrition & Training › Protein & intake · 14 Nov 2025 · 14 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #10 · Sourcing › Independent verification · 11 Nov 2025 · 1 like Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
What pooling buys you and what it destroys Replied, post #56 · Evidence › Meta-analyses · 1 Nov 2025 · 1 like I read post #54 twice before replying, because I had assumed the opposite. Publication bias: what did not get published? Small studies with negative results are less…
-
Documentation that materially improves an appeal's chances Replied, post #40 · Access › Insurance & coverage · 25 Oct 2025 · 18 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Early satiety becoming a problem rather than a benefit Replied, post #3 · Practice › Side effects · 23 Oct 2025 · 2 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Second pass at: Programming during a large energy deficit Replied, post #40 · Nutrition & Training › Resistance training · 15 Oct 2025 · 0 likes Picking up post #37: that is the part I would want checked first. Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires…
-
NHS criteria and how they are applied in practice — the long version Replied, post #7 · Regional › UK & Ireland · 25 Sep 2025 · 0 likes Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #27 · Analytics › Method validation · 22 Sep 2025 · 8 likes Picking up post #24: that is the part I would want checked first. System suitability: injections run at the start of a batch to establish that the instrument and column…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #119 · Compounds › Tirzepatide · 5 Sep 2025 · 29 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #125 · Wellbeing › Mental health · 3 Sep 2025 · 10 likes On post #121 — agreed on the reasoning, with one qualification. Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status…
-
Insurance and replacement policies, compared — the long version Replied, post #11 · Sourcing › Logistics · 1 Sep 2025 · 2 likes This follows post #8 rather than contradicting it. Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #21 · Compounds › Other compounds · 17 Aug 2025 · 0 likes post #20 is right about the mechanism and I think understates the practical bit. Reading a supplier's product description as a marketing document: that is exactly what…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #32 · Data & Tools › Calculators · 23 Jun 2025 · 10 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #10 · Documentation › Doc review · 8 Jun 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #83 · Compounds › Tirzepatide · 13 May 2025 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Follow-up: Documentation that appears only after payment Replied, post #65 · Sourcing › Red flags · 10 May 2025 · 4 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #55 · Compounds › Secretagogues & GH axis · 4 May 2025 · 0 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #13 · Nutrition & Training › Protein & intake · 1 May 2025 · 0 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #119 · Access › International · 24 Mar 2025 · 10 likes This follows post #116 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #102 · Analytics › COA interpretation · 20 Mar 2025 · 10 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #14 · Access › Pricing · 15 Mar 2025 · 26 likes Worth separating two things that post #10 runs together. International pricing: the same compound costs very different amounts in different countries because healthcare…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #103 · Sourcing › Regulatory · 11 Mar 2025 · 0 likes Coming back to post #101, because the follow-up matters more than the original answer. Import restrictions vary by compound and by jurisdiction: what is a controlled…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #21 · Wellbeing › Mental health · 24 Feb 2025 · 0 likes I read post #19 twice before replying, because I had assumed the opposite. Support and community: some people process weight change through community (online or…
-
Distinguishing a deletion sequence by mass alone Replied, post #123 · Analytics › Mass spectrometry · 23 Feb 2025 · 2 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #53 · Pharmacology › Receptor biology · 16 Feb 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
When to suspect the method rather than the sample Replied, post #72 · Analytics › Method validation · 26 Jan 2025 · 0 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #101 · Compounds › Tirzepatide · 10 Jan 2025 · 15 likes Picking up post #98: that is the part I would want checked first. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply…
-
The topic list is dense — is that deliberate? Replied, post #78 · Meta › Site feedback · 6 Jan 2025 · 1 like Picking up post #75: that is the part I would want checked first. Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #66 · Access › Insurance & coverage · 12 Dec 2024 · 32 likes post #65 is right about the mechanism and I think understates the practical bit. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance…
-
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #13 · Compounds › Tirzepatide · 9 Dec 2024 · 12 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Why "any advice?" is the least effective ending for a post Replied, post #113 · Start Here › How to Ask · 6 Dec 2024 · 15 likes Coming back to post #111, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #47 · Evidence › Journal club · 1 Dec 2024 · 30 likes On post #43 — agreed on the reasoning, with one qualification. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy.…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #52 · Analytics › Mass spectrometry · 20 Aug 2024 · 24 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Guidelines revision: what changed and why Replied, post #73 · Meta › Announcements · 27 Jul 2024 · 0 likes post #72 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #4 · Safety › Contraindications · 13 Jul 2024 · 2 likes Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring for hypoglycemia. The combination is used with…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #149 · Practice › Dosing & titration · 11 Jul 2024 · 2 likes Worth separating two things that post #145 runs together. Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over…
-
The mass-error checker and its intended scope Replied, post #61 · Data & Tools › Calculators · 19 Jun 2024 · 0 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…